semaglutide left side pain effects for diabetes and obesity treatment followers #highlights Ozempic is a

Dr Kenneth Custer, Lilly's executive vice president, said: "The 12mg dose delivered a level of weight loss long associated with bariatric surgery." Professor Ania Jastreboff, lead investigator on the trial at Yale School of Medicine, added: "Obesity is a chronic disease, and people living with obesity deserve treatment options that match the complex biology of their neurometabolic disease

Based on a large study conducted by researchers and published in The New England Journal of Medicine, the SELECT trial followed 17,604 adults with overweight or obesity and established cardiovascular disease

Most morning headaches stem from correctable sleep issues like positioning, breathing disorders, or dehydration that develop overnight

Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial

Tirzepatide# Tirzepatide is a 39-amino acid peptide with a C20 fatty diacid side chain that activates two receptors: GIP receptor : Tirzepatide shows approximately 5-fold selectivity for GIP over GLP-1 receptors, representing a GIP-dominant dual agonist GLP-1 receptor : Provides complementary glucose-lowering and appetite-suppressing effects The GIP receptor engagement is a key differentiator from pure GLP-1 agonists like semaglutide